Imatinib mesylate is approved to treat: Acute lymphoblastic leukemia in adults and children that is Philadelphia chromosome positive.
Imatinib
$467.43 – $1,541.73
Only logged in customers who have purchased this product may leave a review.
Shopping Cart
Reviews
There are no reviews yet.